CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland

被引:0
|
作者
Krokowski, M
Bodalski, J
Bratek, A
Machejko, P
Caillat-Zucman, S
机构
[1] Univ Lodz, Inst Pediat, Sch Med, PL-90131 Lodz, Poland
[2] Hop Necker Enfants Malad, Immunol Lab, Paris, France
[3] Hop Necker Enfants Malad, INSERM, U25, Paris, France
来源
DIABETES & METABOLISM | 1998年 / 24卷 / 03期
关键词
CTLA-4; gene; non-HLA genetic factors; polymorphism; DRBI gene; hybridisation;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Susceptibility to insulin-dependent diabetes mellitus (IDDM) is strongly associated with particular HLA class II alleles. However, non-HLA genetic factors are likely to be required for the development of the disease. The candidate genes include the cytoxic T-lymphocyte associated-4 (CTLA-4) gene located on chromosome 2q33, which encodes a cell surface molecule providing a negative signal for T-cell activation. We investigated CTLA-4 exon 1 polymorphism (position 49 A/G) in 192 IDDM children and 136 healthy controls from Central Poland, using allele-specific hybridisation. The CTLA-4/G allele was found on 56.0 % of chromosomes in IDDM patients as compared to 43.4 % in controls (p = 0.002), mostly in homozygous form (31.2 % in patients vs 15.4 % in controls, p = 0.002). This difference was even more pronounced in non-DRB1*03/non-DRB1*04 IDDM patients (GIG genotype frequency. 35.0 % of IDDM patients vs 12.3 % of controls, p = 0.04). Our data indicate that CTLA-4 exon 1 position 49 A/G dimorphism was significantly associated with predisposition to IDDM in our Central Poland population, particularly in patients lacking the strongly predisposing DRB1 alleles.
引用
收藏
页码:241 / 243
页数:3
相关论文
共 50 条
  • [41] Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma
    Wong, YK
    Chang, KW
    Cheng, CY
    Liu, CJ
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2006, 35 (01) : 51 - 54
  • [42] A study of the association between a polymorphism in the CTLA-4 gene and postpartum thyroiditis
    Waterman, EA
    Watson, PF
    Lazarus, JH
    Parkes, AB
    Darke, C
    Weetman, AP
    CLINICAL ENDOCRINOLOGY, 1998, 49 (02) : 251 - 255
  • [43] CTLA-4 gene A-G polymorphism and childhood Graves' disease
    Yung, E
    Cheng, PS
    Fok, TF
    Wong, GWK
    CLINICAL ENDOCRINOLOGY, 2002, 56 (05) : 649 - 653
  • [44] CTLA-4 gene polymorphism in Southern Iranian women with breast cancer
    Yeganeh, F
    Pezeshki, AM
    Talei, A
    Dehaghani, AS
    Doroudchi, M
    Farjadian, S
    Kalantari, T
    Ghaderi, A
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 186 - 186
  • [45] Association of CTLA-4 Gene Polymorphism and Type 2 Diabetes Mellitus
    Chang, Yih-Hsin
    Shiau, Ming-Yuh
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142
  • [46] CTLA-4 gene polymorphism and susceptibility to inflammatory bowel disease (IBD)
    Agarwal, K
    Jones, DEEJ
    Aithal, G
    Daly, A
    Bassendine, MF
    Hudson, M
    GUT, 1999, 44 : A42 - A42
  • [47] CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis
    Agarwal, K
    Jones, DEJ
    Daly, AK
    James, OFW
    Vaidya, B
    Pearce, S
    Bassendine, MF
    JOURNAL OF HEPATOLOGY, 2000, 32 (04) : 538 - 541
  • [48] Association of CTLA-4 gene polymorphism with oral submucous fibrosis in Taiwan
    Shin, YN
    Liu, CJ
    Chang, KW
    Lee, YJ
    Liu, HF
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2004, 33 (04) : 200 - 203
  • [49] CTLA-4 gene polymorphisms and natural soluble CTLA-4 protein in Grave's Disease (GD) in Polish population
    Pawlak, E.
    Daroszewski, J.
    Karabon, L.
    Frydecka, I.
    Slowik, M.
    Jonkisz, A.
    Lebioda, A.
    Dobosz, T.
    Bolanowaski, M.
    TISSUE ANTIGENS, 2007, 69 (05): : 457 - 457
  • [50] CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease
    Takara, M
    Kouki, T
    DeGroot, LJ
    THYROID, 2003, 13 (12) : 1083 - 1089